Published online Jun 16, 2023. doi: 10.4253/wjge.v15.i6.434
Peer-review started: December 21, 2022
First decision: April 13, 2023
Revised: April 14, 2023
Accepted: May 4, 2023
Article in press: May 4, 2023
Published online: June 16, 2023
Processing time: 175 Days and 0.8 Hours
Therapeutic flexible endoscopic robotic systems have been developed primarily as a platform for endoscopic submucosal dissection (ESD) in the treatment of early-stage gastrointestinal cancer. Since ESD can only be performed by highly skilled endoscopists, the goal is to lower the technical hurdles to ESD by introducing a robot. In some cases, such robots have already been used clinically, but they are still in the research and development stage. This paper outlined the current status of development, including a system by the author’s group, and discussed future challenges.
Core Tip: The current status and future issues in the new standardization that therapeutic flexible endoscopic robotic systems have brought to endoscopic submucosal dissection and endoscopic full-thickness resection were outlined.